Breakthroughs in precision medication and individualized cancer therapy boosts demand from customers for cancer biomarkers. The flexibility of biomarkers to detect cancer at its earliest phases, information therapeutic choices, and watch the efficiency of therapy is boosting its adoption across the healthcare market. The market is segmented into protein biomarkers, https://fredw357rrk7.blogsumer.com/profile